Streptomyces xiamenensis

Streptomyces xiamenensis is a bacterium species from the genus of Streptomyces which has been isolated from mangrove sediments in Xiamen in the Fujian Province in China.[1][3][4][5] Streptomyces xiamenensis produces the antifibrotic drug xiamenmycin.[6]

Streptomyces xiamenensis
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. xiamenensis
Binomial name
Streptomyces xiamenensis
Xu et al. 2009[1]
Type strain
CGMCC 4.3534, DSM 41903, JCM 16123, MCCC 1A01550[2]

See also

edit

References

edit
  1. ^ a b LPSN bacterio.net
  2. ^ Straininfo of Streptomyces xiamenensis
  3. ^ Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
  4. ^ UniProt
  5. ^ Xu, J; Wang, Y; Xie, SJ; Xu, J; Xiao, J; Ruan, JS (March 2009). "Streptomyces xiamenensis sp. nov., isolated from mangrove sediment". International Journal of Systematic and Evolutionary Microbiology. 59 (Pt 3): 472–6. doi:10.1099/ijs.0.000497-0. PMID 19244424.
  6. ^ XU, Min-Juan; WANG, Jia-Hua; BU, Xu-Liang; YU, He-Lin; LI, Peng; OU, Hong-Yu; HE, Ying; XU, Fang-Di; HU, Xiao-Yan; Zhu, Xiao-Mei; AO, Ping; Xu, Jun (8 January 2016). "Deciphering the streamlined genome of Streptomyces xiamenensis 318 as the producer of the anti-fibrotic drug candidate xiamenmycin". Scientific Reports. 6: 18977. Bibcode:2016NatSR...618977X. doi:10.1038/srep18977. PMC 4705527. PMID 26744183.

Further reading

edit
edit